The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Letters to the EditorFull Access

Comment on Limbic Hyperactivity in Response to Emotionally Neutral Stimuli in Schizophrenia: A Neuroimaging Meta-Analysis of the Hypervigilant Mind

To the Editor: We read with interest the article by Dugré et al. (1), published in the December 2019 issue of the Journal. The authors suggest that amygdala activity in response to “neutral” stimuli is increased in patients with schizophrenia compared with healthy subjects, and they recommend investigation of at-risk individuals to differentiate cause from effects. We believe that their claim overstates the case and that their suggestion for further study has already been investigated.

First, we are concerned that the investigation of amygdala response to “neutral” stimuli is unlikely to be a scientifically appropriate approach. It is well known that the human amygdala may respond to stimuli presented as “neutral” because of their novelty, ambiguity, and uncertain nature (2, 3). Therefore, the concept of a “neutral” stimulus in a constrained, noisy, and unfamiliar environment such as the MRI machine is questionable. This is even more problematic when comparing two populations with very different mental states, particularly when comparing healthy control subjects, who likely include paid volunteers who have been in the MRI machine many times, and patients with schizophrenia, who likely are less exposed to the MRI research environment. We are concerned that the authors’ conclusions oversimplify complex biological and psychological phenomena.

Our second observation pertains to the authors’ recommendations for further study of individuals at risk for psychosis. Although we certainly agree that studying individuals at risk for schizophrenia (i.e., individuals without the confounding factor of the state of illness) is of crucial importance to differentiate cause from effect, it is surprising that the authors failed to mention a substantial contribution to the scientific literature that reported exactly that. Ten years ago, our group published a study in the Journal whose goal was to disentangle this conundrum. We explored the amygdala response to threatening faces in a relatively large sample of healthy siblings of patients with schizophrenia and compared them with a sample of healthy control subjects. We demonstrated that the abnormal reactivity of the amygdala observed in patients with schizophrenia was not observed in their healthy siblings, suggesting that factors other than genes are implicated in the phenomenon in patients (4).

Another method to explore whether amygdala response is mediated by risk for schizophrenia and not the state of having the illness is to investigate association with polygenic risk scores (PRSs). Using the results from the second meta-analysis from the Psychiatric Genomics Consortium (5) for each healthy participant, we generated polygenic risk profile scores for schizophrenia, which are an index of the cumulative genetic risk across the genome, and we explored whether higher PRSs predict greater amygdala reactivity. We have computed multiple schizophrenia PRSs for a sample of healthy control subjects (N=332) using p value thresholds ranging from p<1 (all linkage disequilibrium–independent single-nucleotide polymorphisms [SNPs]) to p<1×10−8 (genome-wide association study–significant SNPs) and weighted by the logarithm of the odds ratio from results of the second meta-analysis by the Psychiatric Genomics Consortium Schizophrenia Working Group, as described previously (5). All participants were right-handed, and there were 195 females and 137 males. The mean age of participants was 29.4 years (SD=8.9). Mean participant IQ, as measured by the Wechsler Adult Intelligence Scale, was 109.7 (SD=9.0). Results of the association between PRSs and amygdala reactivity are presented in Table 1. None of the individuals’ PRSs analyzed were even remotely predictive of individual amygdala reactivity to threatening stimuli. Our new findings confirm our early work in healthy siblings that exaggerated amygdala responsivity is not risk-associated pathophysiology for schizophrenia.

TABLE 1. Polygenic risk scores (PRSs) and amygdala reactivity of participants in a study of the association between PRSs and amygdala reactivitya

PRS GWAS pZ Values +/− CorrelationFWE-Corrected p
1×10–82.05/2.301/1
1×10–61.75/2.651/1
1×10–4Null/1.94Null/1
0.0012.53/2.861/1
0.011.98/1.941/1
0.052.55/2.001/1
0.12.42/2.221/1
0.22.44/1.961/1
0.52.19/1.951/1
1.02.18/1.991/1

aFWE=family-wise error; GWAS=genome-wide association study.

TABLE 1. Polygenic risk scores (PRSs) and amygdala reactivity of participants in a study of the association between PRSs and amygdala reactivitya

Enlarge table

In summary, we recommend caution in interpretation of data obtained from ambiguous experimental conditions and a more careful evaluation of the results in light of the current scientific literature.

Department of Psychiatry, Medstar Georgetown University Hospital, Washington, DC (Rasetti); Lieber Institute for Brain Development and Maltz Research Laboratories, Baltimore (Chen, Weinberger); Department of Neurology, Department of Neuroscience, Department of Psychiatry and Behavioral Sciences, and McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore (Weinberger).
Send correspondence to Dr. Rasetti ().

The authors report no financial relationships with commercial interests.

References

1 Dugré JR, Bitar N, Dumais A, et al.: Limbic hyperactivity in response to emotionally neutral stimuli in schizophrenia: a neuroimaging meta-analysis of the hypervigilant mind. Am J Psychiatry 2019; 176:1021–1029LinkGoogle Scholar

2 Hariri AR, Tessitore A, Mattay VS, et al.: The amygdala response to emotional stimuli: a comparison of faces and scenes. Neuroimage 2002; 17:317–323Crossref, MedlineGoogle Scholar

3 Sander D, Grafman J, Zalla T: The human amygdala: an evolved system for relevance detection. Rev Neurosci 2003; 14:303–316Crossref, MedlineGoogle Scholar

4 Rasetti R, Mattay VS, Wiedholz LM, et al.: Evidence that altered amygdala activity in schizophrenia is related to clinical state and not genetic risk. Am J Psychiatry 2009; 166:216–225LinkGoogle Scholar

5 Schizophrenia Working Group of the Psychiatric Genomics Consortium: Biological insights from 108 schizophrenia-associated genetic loci. Nature 2014; 511:421–427Crossref, MedlineGoogle Scholar